8-KItem 8.01 · Other EventsItem 9.01 · Financial Statements
AbbVie ($ABBV) 2/24/26 agreed to sell $8.0B of senior notes across seven tranches (2028–2066); pricing…
Filed with the SEC on · Summarized by InvestorsBot
AbbVie ($ABBV) 2/24/26 agreed to sell $8.0B of senior notes across seven tranches (2028–2066); pricing ~par; net proceeds ≈$7.95B. Closing expected Mar 4, 2026. Tranches include FRN + fixed coupons 3.775%–5.65%. 📈🗓️ #ABBV #Bonds #Debt
AbbVie ($ABBV) intends to use proceeds to repay its $4.0B 364‑day delayed‑draw term loan maturing May 2026 (≈$2.0B currently outstanding) and for general corporate purposes, possibly debt repurchases. Underwriters: JPM, BofA, MS, Wells. 💵🔁 #Debt #Pharma